Sign in

CIK 0001678660

  • Non-accelerated filer
  • Smaller reporting company

Prelude Therapeutics Inc

Sign in to watch
Ticker
PRLD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811384762
Phone
+1 302-467-1280
Business address
175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
Former names
Prelude Therapeutics Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-04-29 Pierce Christopher EVP and Chief of Business Oper Exercise or conversion +3,295 $1.89 $6K 7,045
2021-04-29 Pierce Christopher EVP and Chief of Business Oper Sale −3,295 $40.29 $133K 3,750
2021-04-29 Pierce Christopher EVP and Chief of Business Oper Exercise or conversion · Employee Stock Option (right to buy) −3,295 4,323
2021-04-29 Morosini Deborah EVP, Chief of Clinical Affairs Exercise or conversion +3,223 $1.89 $6K 3,667
2021-04-29 Morosini Deborah EVP, Chief of Clinical Affairs Sale −3,223 $40.29 $130K 444
2021-04-29 Morosini Deborah EVP, Chief of Clinical Affairs Exercise or conversion · Employee Stock Option (right to buy) −3,223 4,323
2021-04-27 Mauro David J Chief Medical Officer Exercise or conversion +25,000 $1.89 $47K 25,000
2021-04-27 Mauro David J Chief Medical Officer Sale −7,688 $34.66 $266K 17,312
2021-04-27 Mauro David J Chief Medical Officer Sale −15,601 $35.68 $557K 1,711
2021-04-27 Mauro David J Chief Medical Officer Sale −1,711 $36.11 $62K 0
2021-04-27 Mauro David J Chief Medical Officer Exercise or conversion · Employee Stock Option (right to buy) −25,000 227,610
2021-04-19 Mauro David J Chief Medical Officer Exercise or conversion +25,000 $1.89 $47K 25,000
2021-04-19 Mauro David J Chief Medical Officer Sale −21,000 $30.82 $647K 4,000
2021-04-19 Mauro David J Chief Medical Officer Sale −4,000 $31.27 $125K 0
2021-04-19 Mauro David J Chief Medical Officer Exercise or conversion · Employee Stock Option (right to buy) −25,000 252,610
2021-04-08 Scherle Peggy Chief Scientific Officer Grant or award +4,630 $1.43 $7K 177,550
2021-04-08 Scherle Peggy Chief Scientific Officer Sale −1,417 $36.97 $52K 176,133
2021-04-08 Scherle Peggy Chief Scientific Officer Sale −875 $37.72 $33K 175,258
2021-04-08 Scherle Peggy Chief Scientific Officer Sale −669 $38.97 $26K 174,589
2021-04-08 Scherle Peggy Chief Scientific Officer Sale −1,669 $39.57 $66K 172,920

Page 13 of 19 · 369 trades